SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: quidditch who wrote (2412)4/18/1999 2:28:00 PM
From: Jill  Read Replies (1) of 10280
 
the potential change in pharmaceutical companies' way of doing business if the genome segment of the sector takes off and bypasses the need for "therapeutic" drugs,

boy, that's a way's off--and certainly not going to help most illnesses...a genome approach to multi-factorial and multi-focal illness like depression for example? Or even asthma, which involves a cascade of inflammatory chemicals?

That seems a distant concern.
Jill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News